Evogene Ltd (EVGN)
0.7719
-0.05
(-5.85%)
USD |
NASDAQ |
May 28, 16:00
0.7719
0.00 (0.00%)
After-Hours: 16:13
Evogene Total Assets (Quarterly): 46.78M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 46.78M |
| December 31, 2023 | 51.10M |
| September 30, 2023 | 57.75M |
| June 30, 2023 | 53.34M |
| March 31, 2023 | 49.48M |
| December 31, 2022 | 56.13M |
| September 30, 2022 | 59.39M |
| June 30, 2022 | 56.66M |
| March 31, 2022 | 66.88M |
| December 31, 2021 | 76.30M |
| September 30, 2021 | 83.39M |
| June 30, 2021 | 87.54M |
| March 31, 2021 | 92.78M |
| December 31, 2020 | 71.92M |
| September 30, 2020 | 65.98M |
| June 30, 2020 | 61.11M |
| March 31, 2020 | 64.64M |
| December 31, 2019 | 71.36M |
| September 30, 2019 | 76.44M |
| June 30, 2019 | 53.45M |
| March 31, 2019 | 57.64M |
| December 31, 2018 | 58.69M |
| September 30, 2018 | 63.67M |
| Date | Value |
|---|---|
| June 30, 2018 | 68.09M |
| March 31, 2018 | 72.05M |
| December 31, 2017 | 77.60M |
| September 30, 2017 | 83.10M |
| June 30, 2017 | 87.45M |
| March 31, 2017 | 91.90M |
| December 31, 2016 | 95.99M |
| September 30, 2016 | 101.78M |
| June 30, 2016 | 105.93M |
| March 31, 2016 | 109.03M |
| December 31, 2015 | 112.60M |
| September 30, 2015 | 116.37M |
| June 30, 2015 | 119.86M |
| March 31, 2015 | 123.44M |
| December 31, 2014 | 127.59M |
| September 30, 2014 | 129.76M |
| June 30, 2014 | 131.86M |
| March 31, 2014 | 133.96M |
| December 31, 2013 | 137.31M |
| September 30, 2013 | 59.66M |
| June 30, 2013 | 62.00M |
| December 31, 2012 | 64.86M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
46.78M
Minimum
Mar 2024
92.78M
Maximum
Mar 2021
65.12M
Average
62.88M
Median
Total Assets (Quarterly) Benchmarks
| Compugen Ltd | 113.70M |
| Pluri Inc | 36.39M |
| BioLine Rx Ltd | 63.92M |
| Can Fite Biofarma Ltd | 9.989M |
| BiomX Inc | 81.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.40M |
| Shareholders Equity (Quarterly) | 8.289M |
| Debt to Equity Ratio | 1.248 |
| Current Ratio | 5.062 |
| Net Debt Paydown Yield | -0.12% |